ABOS
Price
$1.07
Change
-$0.02 (-1.82%)
Updated
Apr 1, 04:59 PM (EDT)
Capitalization
65.12M
48 days until earnings call
GBIO
Price
$0.37
Change
-$0.04 (-9.76%)
Updated
Apr 1, 04:59 PM (EDT)
Capitalization
27.14M
29 days until earnings call
Ad is loading...

ABOS vs GBIO

Header iconABOS vs GBIO Comparison
Open Charts ABOS vs GBIOBanner chart's image
Acumen Pharmaceuticals
Price$1.07
Change-$0.02 (-1.82%)
Volume$782
Capitalization65.12M
Generation Bio
Price$0.37
Change-$0.04 (-9.76%)
Volume$14.79K
Capitalization27.14M
ABOS vs GBIO Comparison Chart
Loading...
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABOS vs. GBIO commentary
Apr 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABOS is a StrongBuy and GBIO is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 02, 2025
Stock price -- (ABOS: $1.10 vs. GBIO: $0.41)
Brand notoriety: ABOS and GBIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABOS: 176% vs. GBIO: 83%
Market capitalization -- ABOS: $65.12M vs. GBIO: $27.14M
ABOS [@Biotechnology] is valued at $65.12M. GBIO’s [@Biotechnology] market capitalization is $27.14M. The market cap for tickers in the [@Biotechnology] industry ranges from $302.51B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABOS’s FA Score shows that 0 FA rating(s) are green whileGBIO’s FA Score has 0 green FA rating(s).

  • ABOS’s FA Score: 0 green, 5 red.
  • GBIO’s FA Score: 0 green, 5 red.
According to our system of comparison, GBIO is a better buy in the long-term than ABOS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABOS’s TA Score shows that 5 TA indicator(s) are bullish while GBIO’s TA Score has 5 bullish TA indicator(s).

  • ABOS’s TA Score: 5 bullish, 3 bearish.
  • GBIO’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, both ABOS and GBIO are a good buy in the short-term.

Price Growth

ABOS (@Biotechnology) experienced а -11.29% price change this week, while GBIO (@Biotechnology) price change was -18.28% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -9.07%. For the same industry, the average monthly price growth was -13.26%, and the average quarterly price growth was -12.25%.

Reported Earning Dates

ABOS is expected to report earnings on May 20, 2025.

GBIO is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Biotechnology (-9.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABOS($65.1M) has a higher market cap than GBIO($27.1M). ABOS YTD gains are higher at: -36.047 vs. GBIO (-61.792). GBIO (-74.26M) and ABOS (-77.89M) have comparable annual earnings (EBITDA) . ABOS has more cash in the bank: 200M vs. GBIO (185M). ABOS has less debt than GBIO: ABOS (28.5M) vs GBIO (93.6M). GBIO has higher revenues than ABOS: GBIO (19.9M) vs ABOS (0).
ABOSGBIOABOS / GBIO
Capitalization65.1M27.1M240%
EBITDA-77.89M-74.26M105%
Gain YTD-36.047-61.79258%
P/E RatioN/AN/A-
Revenue019.9M-
Total Cash200M185M108%
Total Debt28.5M93.6M30%
TECHNICAL ANALYSIS
Technical Analysis
ABOSGBIO
RSI
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 9 days ago
77%
Bullish Trend 15 days ago
85%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
83%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Ad is loading...
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MLM478.130.13
+0.03%
Martin Marietta Materials
CNNE18.33-0.19
-1.03%
Cannae Holdings
HXL54.76-1.55
-2.75%
Hexcel Corp
DDL2.70-0.11
-3.91%
Dingdong (Cayman) Limited
XGN3.59-0.25
-6.51%
Exagen

ABOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABOS has been loosely correlated with FHTX. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if ABOS jumps, then FHTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABOS
1D Price
Change %
ABOS100%
-7.56%
FHTX - ABOS
51%
Loosely correlated
+3.69%
ATOS - ABOS
50%
Loosely correlated
-3.35%
GBIO - ABOS
49%
Loosely correlated
-5.33%
ALEC - ABOS
48%
Loosely correlated
-4.65%
ATXS - ABOS
47%
Loosely correlated
-6.32%
More

GBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, GBIO has been loosely correlated with ABOS. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if GBIO jumps, then ABOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GBIO
1D Price
Change %
GBIO100%
-5.33%
ABOS - GBIO
49%
Loosely correlated
-7.56%
ATNM - GBIO
46%
Loosely correlated
-11.05%
AURA - GBIO
45%
Loosely correlated
-7.57%
ATOS - GBIO
44%
Loosely correlated
-3.35%
FHTX - GBIO
44%
Loosely correlated
+3.69%
More